The immunophenotype and activation status of the lymphocytic infiltrate in human breast cancers, the role of the major histocompatibility complex in cell-mediated immune mechanisms, and their association with prognostic indicators

This publication has 29 references indexed in Scilit:

• Immunogene therapy with interleukin-2—secreting fibroblasts for intracerebrally metastasizing breast cancer in mice
  Journal of Neurosurgery, 2001
• High-dose cyclophosphamide + carboplatin and interleukin-2 (IL-2) activated autologous stem cell transplantation followed by maintenance IL-2 therapy in metastatic breast carcinoma – a phase II study
  Bone Marrow Transplantation, 2000
• Review Article The immunology and immunotherapy of breast cancer: an update
  International Journal of Immunopharmacology, 1999
• Combination Therapy with Interleukin-2 and Wild-Type p53 Expressed by Adenoviral Vectors Potentiates Tumor Regression in a Murine Model of Breast Cancer
  Human Gene Therapy, 1998
• Local low-dose interleukin-2 induces systemic immunity when combined with radiotherapy of cancer. A pre-clinical study
  International Journal of Cancer, 1997
• Anti-tumor effects of local irradiation in combination with peritumoral administration of low doses of recombinant interleukin-2 (rIL-2)
  Radiation Oncology Investigations, 1997
• Quantitative immunohistochemical analysis of mononuclear infiltrates in breast carcinomas–correlation with tumour differentiation
  The Journal of Pathology, 1990
• Same peculiar subset of HML1 + lymphocytes present within normal intestinal epithelium is associated with tumoral epithelium of gastrointestinal carcinomas.
  Gut, 1988
• Immunohistochemical analysis of HLA antigens and mononuclear infiltrates of benign and malignant breast
  The Journal of Pathology, 1987
• Mononuclear cells infiltrating human mammary carcinomas: Immunohistochemical analysis with monoclonal antibodies
  International Journal of Cancer, 1985